IM
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ·Healthcare·Biotechnology
$4.21
+9.64%
Mkt Cap $154.79M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $285.00K | $1.14M | +299.65% | -$0.24 | -$0.27 | -13.68% | — | — |
| Q4 2025 Nov 10, 2025 | $285.00K | $260.00K | -8.77% | -$0.24 | -$0.34 | -41.67% | — | — |
| Q3 2025 Aug 11, 2025 | $300.00K | $518.00K | +72.67% | -$0.23 | -$0.30 | -30.43% | — | — |
| Q2 2025 May 12, 2025 | $126.78K | $2.14M | +1586.39% | -$0.24 | -$0.26 | -8.33% | — | — |
| Q1 2025 Mar 24, 2025 | $158.55K | $1.49M | +837.24% | -$0.43 | $0.48 | +211.63% | — | — |
| Q4 2024 Nov 12, 2024 | $101.67K | $115.00K | +13.11% | -$0.44 | -$0.98 | -122.73% | — | — |
| Q3 2024 Aug 8, 2024 | $320.00K | $104.00K | -67.50% | -$0.56 | -$0.36 | +35.71% | — | — |
| Q2 2024 May 15, 2024 | $350.00K | $176.00K | -49.71% | -$0.67 | -$1.13 | -68.66% | — | — |
| Q1 2024 Mar 29, 2024 | — | $314.00K | — | -$1.57 | -$1.94 | -23.30% | — | — |
| Q4 2023 Nov 9, 2023 | $320.00K | $429.00K | +34.06% | -$1.52 | -$0.57 | +62.50% | — | — |
| Q3 2023 Aug 10, 2023 | $360.00K | $463.00K | +28.61% | -$2.60 | -$1.07 | +58.85% | — | — |
| Q2 2023 May 11, 2023 | $350.00K | $297.00K | -15.14% | -$2.40 | -$0.80 | +66.67% | — | — |
| Q1 2023 Mar 29, 2023 | $1.42M | -$3.55M | -350.00% | -$0.09 | -$7.64 | -8385.46% | — | — |
| Q4 2022 Nov 10, 2022 | $1.48M | $1.02M | -31.50% | -$2.60 | -$1.60 | +38.46% | — | — |
| Q3 2022 Aug 10, 2022 | $2.71M | $2.07M | -23.60% | -$2.60 | -$1.40 | +46.15% | — | — |
| Q2 2022 May 11, 2022 | $2.24M | $1.42M | -36.48% | -$2.60 | -$2.20 | +15.38% | — | — |
| Q1 2022 Mar 10, 2022 | $3.52M | $3.59M | +1.85% | -$2.00 | -$2.00 | +0.00% | — | — |
| Q4 2021 Nov 9, 2021 | $1.75M | $984.00K | -43.88% | -$1.40 | -$2.20 | -57.14% | — | — |
| Q3 2021 Aug 10, 2021 | $1.57M | $2.03M | +29.30% | -$1.60 | -$1.60 | +0.00% | — | — |
| Q2 2021 May 17, 2021 | $840.00K | $1.12M | +33.81% | -$1.80 | -$0.80 | +55.56% | — | — |